The Suggestive Gene

Langreth, Robert
September 2006
Forbes Asia;9/4/2006, Vol. 2 Issue 14, p118
The article focuses on the decision of Celera to venture into the diagnostic testing segment. The company tried to sell data from its gene storehouse and then create a production line of wonder drugs to treat cancer and autoimmune disorders but the venture failed to make profits. The company is planning to introduce a test in 2007 called the coronary heart disease genetic risk score.


Related Articles

  • Neglecting women's hearts.  // Consumer Reports on Health;May94, Vol. 6 Issue 5, p54 

    Reports on the study about the frequency of diagnostic tests and therapeutic interventions for coronary heart disease among women. Comparison with attitudes of men on tests; Relevance of gender on the diagnosis and treatment of coronary disease.

  • Blood-pressure exercise warning.  // Consumer Reports on Health;Aug96, Vol. 8 Issue 8, p89 

    Mentions that a spike in the blood pressure level during exercise can serve as a stronger predictor of a coronary-heart-disease risk. Basis of claim.

  • It's too early to recommend ultrafast CT as a coronary screening tool, says AHA.  // Modern Medicine;Nov96, Vol. 64 Issue 11, p13 

    Cautions against the use of computed tomography method for screening coronary heart disease patients, based on the recommendations of the American Heart Association. Investigation on the efficiency and accuracy of the test; Risk of fast but inaccurate cardiac diagnostic results.

  • More evidence that earlobe creases mean trouble for CAD patients.  // Modern Medicine;Jul96, Vol. 64 Issue 7, p50 

    Presents an abstract on the article `Diagonal Earlobe Creases and Prognosis in Patients With Suspected Coronary Artery Disease,' by W.J. Elliott and L.H. Powell published in the February 1996 issue of the `American Journal of Medicine'.

  • TIA: How to know which patients will have major vascular events.  // Geriatrics;Aug93, Vol. 48 Issue 8, p67 

    Reports on a study indicating the characteristics which predict the occurrence of a major vascular event in a patient who has had a transient ischemic attack (TIA) or minor stroke. Presence of diabetes; Computerized tomography evidence of a border zone infarct; Independent risk factors.

  • Here's more evidence that earlobe creases spell trouble in CAD patients. Leibovitch, Eric R. // Geriatrics;Aug96, Vol. 51 Issue 8, p65 

    Discusses the study `Diagonal earlobe creases and prognosis in patients with suspected coronary artery disease,' by W.J. Elliott and L.H. Powell.

  • Diagnosing CAD.  // Geriatrics;Jan98, Vol. 53 Issue 1, p25 

    Focuses on the utilization of an arbutamine HCl injection (GenESA) system to diagnose coronary artery disease (CAD). Details on the system; Statistical findings of clinical trials using the system.

  • What erodes the female CHD advantage. Pinkowish, Mary Desmond // Patient Care;3/15/1995, Vol. 29 Issue 5, p110 

    Presents the reprint of `Risk factors that attenuate the female coronary disease advantage,' by WB Kannel, PWF Wilson in `Arch Intern Med 1995.'

  • CAD: It's not only what you eat, but what eats you.  // Modern Medicine;Jan95, Vol. 63 Issue 1, p42 

    Presents an abstract of the article `Hostility in Asymptomatic Men With Angiographically Confirmed Coronary Artery Disease,' by J.C. Barefoot, J.C. Patterson et al from the American Journal of Cardiology dated September, 1994.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics